July 09, 2021

Alzheimer’s and Covid-19 developers make hay on the stock markets

Big risers include Eli Lilly, Biogen, Moderna and Biontech.

May 19, 2021

Glaxo’s Covid-19 effort progresses, this time thanks to Medicago

April 22, 2021

Valneva joins the phase 3 Covid-19 vaccine club

Meanwhile, Ocugen hopes that Covaxin's India data will be enough for US approval.

February 19, 2021

Immunome soars 76% on Covid-19 hopes – but that's nothing